AUCTORES
Globalize your Research
Case Report | DOI: https://doi.org/10.31579/2690-1919/044
1 Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
2 Growth and development research center,childrens medical center, Tehran University of Medical Sciences, Tehran, Iran.
*Corresponding Author: Manouchehr Nakhjavani, Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
Citation: Reza Mohamad hosseinzade Davatgari, Soghra Rabizadeh, Azin Ghamari, Alireza Esteghamati, Manouchehr Nakhjavani (2020) Ectopic Acth-Producing Pulmonary Carcinoid: A Rare Case of Simulating the Cushing’s disease. J Clinical Research and Reports, 3(4); DOI:10.31579/2690-1919/044
Copyright: © 2020 Manouchehr Nakhjavani. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 16 February 2020 | Accepted: 09 March 2020 | Published: 12 March 2020
Keywords: adrenocorticotropic; ectopic cushing’s syndrome; lung carcinoid tumor
Excess amounts of blood glucocorticosteroids, either exogenous or endogenous, results in Cushing’s syndrome (CS). the current study presents a 45-year-old man, ACTH dependent Cushing’s syndrome. The basal cortisol and urine free cortisol level were significantly suppressed following high dose dexamethasone suppression test and pituitary MRI showed microadenoma with a size of less than 6 mm. After bilateral inferior petrosal sinus sampling, we investigated the ectopic source of ACTH production. The computed tomography revealed a mediastinal lymph node, and the whole body octreotide scan revealed octreotide avid lesion in the medial aspect of the left lung. The patient underwent left lung lobectomy and the pathological study indicated the carcinoid tumor of the left lung.
Excess amounts of blood glucocorticosteroids, either exogenous or endogenous, results in Cushing’s syndrome (CS)[1]. In about 10% of cases with Adrenocorticotropic hormone (ACTH) dependent Cushing’s syndrome, hypercortisolism develops due to hypersecretion of ACTH from a non-pituitary neuroendocrine tumor (EAS) [2-5] . The association of CS with ectopic adrenocorticotropic hormone (ACTH) secretion was described in 1962 [6, 7]. This study is going to describe a rare case of CS due to an ectopic ACTH producing tumor presented simulating to Cushing disease ( pituitary origin) according to the clinical and laboratory findings.
A 45-year-old man was referred to our institution due to fatigue, generalized bone pain, proximal muscle weakness, weight gain, facial swelling since one year before the visit. The past medical history, past surgical history and family history, was unremarkable. There was no history of drug consumption, as well. Initial physical examination revealed central obesity, moon face, facial plethora, lower extremity proximal muscle weakness (4/5), positive Govern sign, violaceous striae (width > 1cm) in abdomen & flanks, blood pressure of 135/85 mmHg, pulse rate of 75 beats per minute, weight of 72 kilograms, height of 175 centimeters and body mass index of 23.5 Kg/m2. Laboratory tests: sodium: 140 meq/lit, K: 3.8 meq/lit , FBS:110mg/dl, creatinine:0.8 mg/dl, bicarbonate: 24 meq/lit .
Urine free cortisol was high on two occasions (1240 and 1465 µg/ 24h ) and due to a very high level of urine free cortisol, the low dose dexamethasone suppression test was not performed. ACTH level was 125 pg/ml. further evaluation including high dose dexamethasone suppression test (HDDST)(2 mg dexamethasone every 6 hours for 48 hours) and pituitary MRI were done. The morning serum cortisol and urine free cortisol (UFC) levels were suppressed more than 90 % from baseline following high dose dexamethasone suppression test (HDDST) (table 1).
UFC (base) | UFC (HDDST) | Cortisol (base) | Cortisol (HDDST) | ACTH |
1465 µg/24
| 46 µg /24h
| 20.6 µg /dl | 1.75 µg /dl | 125 Pg/ml |
Table 1: UFC and serum morning cortisol measured at baseline and after high dose dexamethasone suppression test.
UFC: urine free cortisol; HDDST: high dose dexamethasone suppression test; ACTH: adrenocorticotropic hormone.
The pituitary magnetic resonance imaging (MRI) indicated a 2.8mm microadenoma in the midline of pituitary gland (figure 1). Because the size of microadenoma was less than 6 mm, bilateral inferior petrosal sinus sampling (BIPSS) was done. The results were presented in table 2. Results of BIPSS showed no central to peripheral gradient in ACTH and pituitary origin for ACTH excess was ruled out.
ACTHACTH (Pg/ml) | IPS | Peripheral | IPS/Peripheral ratio | ||
Right | Left | Right | Left | ||
-15 | 83.9 | 79.9 | 80.1 | 1.04 | 0.99 |
-10 | 89.9 | 90.2 | 79.3 | 1.13 | 1.13 |
-5 | 84.1 | 80.8 | 77.8 | 1.08 | 1.03 |
0 | 87.2 | 85 | 74.9 | 1.16 | 1.13 |
+3 | _ | 148 | 92.8 | _ | 1.59 |
+5 | 215 | 211 | 154 | 1.39 | 1.37 |
+8 | 239 | 242 | 208 | 1.14 | 1.16 |
+10 | 239 | 248 | 207 | 1.15 | 1.19 |
+15 | 223 | 229 | 189 | 1.17 | 1.21 |
Prolactin(ng/dl) | 16.9 | 16.3 | 3.2 |
|
|
Table 2: The laboratory results following inferior petrosal sinus sampling (IPSS)
ACTH: Adrenocorticotropic hormone; IPS: inferior petrosal sinus;
For the investigation of the source of ectopic Cushing’s syndrome The computed tomography (CT) scan of the chest and abdominopelvic was performed. CT scan indicated a mediastinal lymph node and a nodule located in the left lung. The whole body sintigraphy scan with 8 mci TC-99m- octerotide revealed octreotide avid lesion in the medial aspect of the left lung.
The left lung lobectomy was performed and pathological assessments indicated a typical carcinoid tumor. The immunohistochemistry study of tumor and lymph node was positive for ACTH, which was in favor of ectopic ACTH-producing Cushing’s syndrome. The cortisol level following the left lung lobectomy was low and the patient received hydrocortisone.
This study presents a rare case of ectopic ACTH-producing Cushing’s syndrome due to pulmonary carcinoid. The srum cortisol level and UFC were suppressed significantly ( more than 90%) on the high dose dexamethasone suppression test (HDDST), which is more favorable for pituitary cause of hypercortisolism (cushing disease) (table1). Also, the pituitary MRI showed a microadenoma with a size less than 6mm (figure 1).
Therefore, the BIPSS was performed which revealed the ectopic origin of the ACTH production (EAS). The chest CT scan showed a mediastinal lymph node and a nodule in the left lung and whole body octreotide scan confirmed the diagnosis.
The suppression of the serum cortisol level after the HDDST has commonly occurred in Cushing disease [8]. The point that makes this case interesting was that although HDDST was in favor of Cushing disease and a microadenoma was found in pituitary MRI , the diagnostic evaluations, followed by diagnostic algorithms, led to the diagnosis of the ectopic ACTH producing carcinoid.
The ACTH-dependent CS results from ectopic ACTH secretion is rare, but is severe and is associated with elevated mortality and morbidity in cases left untreated. It is mostly due to neuroendocrine tumors located somewhere other than the pituitary gland. It could be originated from lung small cell carcinoma, larynx, esophagus, urinary bladder and urogenital system [9, 10]. Nearly half of the cases comprise small cell carcinoma and carcinoid of the lung [11]. It castles the light on the point that it is better to assess the lungs first for finding the ectopic source. The most common malignancy which is associated with EAS is considered bronchopulmonary carcinoids [12]. These patients usually have not pulmonary symptoms; moreover, sometimes these tumors are too small to be detected on imagining modalities but they are hormonally active [12] [13]; therefore, the diagnosis could be delayed months to years [13] [14].
The presented patient did not have any pulmonary symptoms and the diagnosis of the carcinoid tumor of the lung was definitive one year following the appearance of the symptoms of hypercortisolism.
Imaging and hormonal assessments are able to differentiate the Cushing disease (CD) and EAS; although there are still difficulties in this regard for some patients, especially whose pathologic lesion was not detected by pituitary MRI. This is not even uncommon for patients diagnosed with CD; approximately 40-50% of patients diagnosed with CD surgically had no abnormal MRI [15, 16]; on the other hand, 10% of healthy subjects have pituitary incidentaloma on MRI evaluations [17], which higher prevalence could be anticipated as more sophisticated MRI equipment emerge. It can be concluded that the differentiation between pituitary incidentaloma and EAS could be a challenging issue. Other tests such as high dose dexamethasone suppression test (HDDST) is an acceptable tool for differentiating the conditions; although there is still margin of uncertainty for the accurate localization of the pathologic lesion; in contrast to other diagnostic modalities, bilateral inferior petrosal sinus sampling (BIPSS) is a more powerful modality for differentiating the CD and EAS. BIPSS is able to differentiate the pituitary-origin hypercortisolism from non-pituitary origin [18], but it cannot localize the site of the ectopic lesion. The BIPSS in this patient was in favor of EAS and further imaging studies, including chest CT scan which indicated mediastinal lymph node and the whole body octreotide scan indicated abnormal mass in the left lung.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
